With the redefinition of myocardial infarction in 2000, cardiology associations ESC and ACC require the use of the 99th percentile of a healthy population at a coefficient of variation (CV) of less than 10 % for Troponin values in diagnosing myocardial infarction. With a new Troponin T high sensitive (TnThs) assay as an advancement, it is now possible to fulfill these requirements. A panel of experts from laboratories and cardiologists discussed how to use this new assay in daily routine. Their experience confirms the excellent correlation between the upper measuring range of the new, highly sensitive Troponin T high sensitive test and the values obtained for Troponin T (4th generation). The Troponin T high sensitive test will identify more patients with myocardial infarction when using Troponin Ths above the 99t percentile (14 pg/mL). To diagnose myocardial infarction, one Troponin T value above the 99th percentile, a rise or fall within hours, and symptoms of ischemia need to be applied. Patients with elevated Troponin T levels but without myocardial infarction are supposed to have myocardial damage due to other reasons and have a rather poor prognosis. Is one of the criteria is not fulfilled, a myocardial infarction is less probable and differential diagnosis needs to be conducted.
Download full-text PDF |
Source |
---|
Ann Transl Med
December 2024
Department of Cardiovascular Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
Background: Patients with end-stage kidney disease (ESKD) are at high risk for coronary artery disease. We investigate the trends and outcomes of percutaneous coronary intervention (PCI) for stable ischemic heart disease (SIHD) in patients with ESKD.
Methods: We utilized the United States Renal Data System [2010-2018] to include adult patients with ESKD on dialysis for at least 3 months who underwent PCI for SIHD.
Purpose: We designed a study investigating the cardioprotective role of sleep apnea (SA) in patients with acute myocardial infarction (AMI), focusing on its association with infarct size and coronary collateral circulation.
Methods: We recruited adults with AMI, who underwent Level-III SA testing during hospitalization. Delayed-enhancement cardiac magnetic resonance (CMR) imaging was performed to quantify AMI size (percent-infarcted myocardium).
JACC Adv
December 2024
Department of Cardiology, Aga Khan University Hospital, Nairobi, Kenya.
JACC Adv
December 2024
Interventional Cardiology Department, Abidjan Heart Institute, Abidjan, Côte d'Ivoire.
Background: Whereas the increasing burden of acute myocardial infarction (MI) has been reported in sub-Saharan Africa, little is known about short- and long-term prognosis following acute MI.
Objectives: The purpose of this study was to assess in-hospital, 30-day, and 1-year all-cause mortality and adverse outcomes in patients with MI hospitalized at a cardiac center in Côte d'Ivoire.
Methods: This prospective cohort study used data from the REgistre des syndromes coronariens Aigus de CôTe d'IVoire (REACTIV).
JACC Adv
December 2024
Department of Medicine, Reading Hospital, Tower Health, West Reading, Pennsylvania, USA.
Background: Coronary artery disease (CAD) and acute myocardial infarction (AMI) still pose a significant burden to the health care system, affecting population subgroups differently.
Objectives: The purpose of the study was to describe age, sex, and racial disparities in mortality rates for CAD and AMI in the United States between 2000 and 2020.
Methods: This was an ecological study with trend analysis of mortality rates using data from the National Centers for Disease Control and Prevention surveillance databases.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!